— Know what they know.
Not Investment Advice

NXTC NASDAQ

NextCure, Inc.
1W: +0.2% 1M: -30.8% 3M: +145.9% YTD: -61.7% 1Y: -10.5% 3Y: -67.6% 5Y: -94.0%
$5.09
+0.13 (+2.62%)
 
Weekly Expected Move ±12.7%
$4 $4 $5 $6 $6
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 28 · $18.4M mcap · 2M float · 94.41% daily turnover · Short 39% of daily vol

Balance Sheet Trends

Total Assets
$50M -37.9% ▼
5Y CAGR: -30.4%
Total Liabilities
$15M -1.0% ▼
5Y CAGR: +3.4%
Shareholders Equity
$35M -46.6% ▼
5Y CAGR: -34.7%
Cash & Investments
$42M -39.1% ▼
5Y CAGR: -31.8%
Total Debt
$4M -30.3% ▼
5Y CAGR: +3.6%
Net Debt
-$22M -0.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$12M$27M$13M$28M$26M
Short-Term Investments$207M$133M$95M$41M$16M
Cash & ST Investments$220M$160M$108M$69M$42M
Net Receivables$0$700K$800K$300K$100K
Inventory$0-$700K$0$0$0
Other Current Assets$39K$4M$4M$3M$2M
Total Current Assets$228M$164M$113M$72M$44M
Property, Plant & Equip.$14M$17M$13M$9M$6M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$577K$2M$2M$332K$546K
Total Non-Current Assets$15M$20M$15M$9M$6M
Total Assets$242M$184M$128M$81M$50M
— Liabilities —
Accounts Payable$2M$4M$2M$5M$2M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$3M$3M$113K$2M$9M
Total Current Liabilities$7M$9M$7M$10M$11M
Long-Term Debt$0$0$0$0$4M
Other Non-Current Liab.$2M$899K$785K$661K$526K
Total Non-Current Liabilities$2M$8M$7M$6M$5M
Total Liabilities$9M$17M$14M$15M$15M
— Equity —
Common Stock$28K$28K$28K$28K$4K
Retained Earnings-$187M-$262M-$324M-$380M-$436M
Accumulated OCI-$663K-$1M-$222K$4K$21K
Total Stockholders Equity$233M$168M$114M$65M$35M
Total Liabilities & Equity$242M$184M$128M$81M$50M
— Key Metrics —
Total Debt$0$7M$7M$6M$4M
Net Debt-$12M-$20M-$6M-$22M-$22M
Total Investments$207M$133M$95M$41M$16M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms